Tivic Health Systems, Inc.
NASDAQ: TIVC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael Kevin Handley
- Employees
- 52
- Headquarters
- Fremont, United States
- IPO year
- 2021
- Market cap
- $572.0K
- Website
- https://tivichealth.com
Loading TIVC…
Loading profile data…Frequently asked questions about TIVC
What does Tivic Health Systems, Inc. (TIVC) do?
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized varia...
Where does TIVC trade?
Tivic Health Systems, Inc. (TIVC) trades on the NASDAQ.
What sector is TIVC in?
Tivic Health Systems, Inc. (TIVC) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Tivic Health Systems, Inc.?
Michael Kevin Handley is the chief executive officer of Tivic Health Systems, Inc. (TIVC).
Where is Tivic Health Systems, Inc. headquartered?
Tivic Health Systems, Inc. is headquartered in United States.
Does TIVC pay a dividend?
Tivic Health Systems, Inc. (TIVC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TIVC go public?
Tivic Health Systems, Inc. (TIVC) completed its initial public offering in 2021.